|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.580 SEK | -1.61% |
|
-2.72% | -36.44% |
| 07/07 | Vivesto chairman Peter Zonabend increases his shareholding | FW |
| 01/07 | Vivesto Completes Enrollment in Cat Study of Paccal Vet | FW |
| Market Cap | 9.65Cr 1Cr 87.57L 80.96L 74.79L 1.41Cr 96Cr 1.43Cr 3.79Cr 47Cr 3.76Cr 3.68Cr 162.29Cr | P/E 2026 * |
-2.85x | P/E 2027 * | -2.08x |
|---|---|---|---|---|---|
| Enterprise Value | 8.85Cr 91.91L 80.32L 74.25L 68.6L 1.29Cr 88Cr 1.32Cr 3.47Cr 43Cr 3.45Cr 3.38Cr 148.84Cr | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
56.4% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Vivesto AB
| 1 day | -1.61% | ||
| 1 week | -2.72% | ||
| Current month | +0.94% | ||
| 1 month | -5.71% | ||
| 3 months | +5.93% | ||
| 6 months | -17.82% | ||
| Current year | -36.44% |
| 1 week | 8.25 |  | 9.07 |
| 1 month | 8 | | 9.8 |
| Current year | 7 | | 19.5 |
| 1 year | 7 | | 31.9 |
| 3 years | 7 | | 90.6 |
| 5 years | 7 | | 319 |
| 10 years | 7 | | 1,670 |
| Manager | Title | Age | Since |
|---|---|---|---|
Erik Kinnman
CEO | Chief Executive Officer | 68 | 23/01/2023 |
Björn Svanström
DFI | Director of Finance/CFO | 55 | 01/07/2026 |
| Chief Tech/Sci/R&D Officer | 39 | 01/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 46 | 25/05/2022 | |
Hege Hellstrom
BRD | Director/Board Member | 61 | 26/09/2019 |
Pål Ryfors
BRD | Director/Board Member | 43 | 25/05/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25/22/25 | Buy | Chief Executive Officer | 12,200 | 0.0027% | ||
| 24/22/24 | Others | Chairman | 1,20,000 | 0.0268% | ||
| 20/21/20 | Free | Chief Executive Officer | 22,50,000 | 0.5018% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.61% | -2.72% | -62.94% | -67.80% | 1Cr | |
| -0.56% | -6.72% | +44.19% | +156.43% | 1,02800Cr | |
| +0.44% | -5.01% | +61.87% | +58.79% | 61TCr | |
| -0.01% | -3.88% | +27.81% | +79.97% | 43TCr | |
| +0.12% | -2.18% | +28.47% | +22.15% | 32TCr | |
| -0.82% | -3.37% | +26.65% | +43.26% | 28TCr | |
| +0.49% | -12.65% | +18.50% | +21.94% | 26TCr | |
| +1.70% | 0.00% | -25.39% | -39.71% | 22TCr | |
| +0.04% | -3.49% | +19.60% | +56.20% | 19TCr | |
| -0.02% | -4.63% | +16.01% | +68.47% | 16TCr | |
| Average | -0.07% | -5.11% | +15.48% | +39.97% | 34.98TCr | |
| Weighted average by Cap. | -0.21% | -5.52% | +33.57% | +76.98% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -3.1Cr -32.18L -28.12L -25.99L -24.02L -45.23L -31Cr -46.05L -1.22Cr -15Cr -1.21Cr -1.18Cr -52Cr | -4.6Cr -47.75L -41.73L -38.57L -35.64L -67.11L -46Cr -68.33L -1.8Cr -22Cr -1.79Cr -1.75Cr -77Cr |
| Net Debt | -80L -8L -7L -7L -6L -11.67L -7.98Cr -11.88L -31.39L -3.91Cr -31.19L -30.5L -13Cr | -1Cr -10.38L -9L -8L -8L -14.59L -9.97Cr -14.85L -39.23L -4.88Cr -38.99L -38.13L -17Cr |
Employees
4
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/26/15 | SEK 8.580 | -1.61% | 3,107 |
| 14/26/14 | SEK 8.720 | +3.32% | 4,907 |
| 13/26/13 | SEK 8.440 | -0.12% | 13,974 |
| 10/26/10 | SEK 8.450 | -1.63% | 5,552 |
| 09/26/09 | SEK 8.590 | -2.61% | 16,750 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- VIVE Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
